上海市第十人民医院科研处副处长/泛血管中心主任/高血压中心主任；上海市优秀技术带头人；5848vip威尼斯电子游戏高等研究院 研究员；兼任中华医学会内科学分会青年副主任委员；上海医学会心血管病分会高血压学组 副组长；第十八届上海市卫生系统“银蛇奖”提名奖获得者；中国心血管医生创新俱乐部 执行委员。
Deputy Director of the Science and Research Dep. , and director of the Pan-vascular Center and the Hypertension Center of the Shanghai Tenth People’s Hospital; Shanghai Outstanding Technical Leader; Researcher, Institute of Advanced Science Institute, Tongji University ; Vice youth president of the Internal Medicine Branch of the Chinese Medical Association; Deputy leader of the Hypertension Group of the Cardiovascular Branch of the Shanghai Medical Association; Nominee of the 18th Shanghai Health System "Silver Snake Award"; Executive member of the Chinese Cardiovascular Innovation Club (CCI).
在心血管预防与预警领域已发表SCI文章88篇，总影响因子为425分，其中第一作者或通讯作者SCI论文62篇（总影响因子255分, >10分4篇），最高单篇影响因子16.8分，总被引1238次，H-index 23。一篇论文曾获美国AHA Hypertension杂志年度最佳临床型论文奖，单篇被引196次。一篇2017年发表在JAHA杂志文章总被引用230次，被ESI评为高被引论文。2020年与Bryan Williams教授联合在Lancet杂志（IF=79）发表评论性文章。主持国家自然科学基金4项，上海市卫计委优青项目1项，上海市申康生物样本全息库建设项目2项。曾获中华医学会心血管病分会中青年心血管病学“菁英奖”；5848vip威尼斯电子游戏首届十佳医务青年；东方心脏病学会东方新星提名奖；上海市卫生系统“新优青”。曾获中国中医药促进会科技进步一等奖，中华医学科技进步二等奖，上海市医学科技奖三等奖。现任美国心脏病协会委员（FACC），欧洲心脏病协会委员（FESC），欧洲高血压协会（ESH）委员，国际高血压学会（ISH）委员。任《中国心血管病研究杂志》、《中国循证医学杂志》和《中国介入心脏病杂志》青年编委。任Hypertension、Artificial Intelligence Review等杂志的审稿人。目前获得国家发明专利5项，实用新型专利10项。
88 SCI articles have been published in the field of cardiovascular prevention and alerting, with a total impact factor of 425 points, including 62 SCI papers by the first author or corresponding author (total impact factor 255 points, 4 articles with IF >10), the highest single article impact factor is 16.8 points, with a total of 1238 citations, H-index 23. A paper has won the annual best clinical paper award in AHA journal Hypertension, with a citation of 196. An article published in JAHA in 2017 has been cited 230 times and was rated as a highly cited paper by ESI. In 2020, he and Professor Bryan Williams jointly published a commentary in Lancet (IF=79). Presided over 4 National Natural Science Foundation of China, 1 Excellent Youth Project of Shanghai Health and Family Planning Commission, and 2 Shanghai ShenKang Biobank Construction Project. Won the "Elite Award" by the Cardiovascular Branch of the Chinese Medical Association; Tongji University's first ten best medical youths; Oriental Rising Star Nomination Award from the Oriental Society of Cardiology; Shanghai Health System "New Excellent Youth". He has won the first prize of Science and Technology Progress Award of China Association for the Promotion of Traditional Chinese Medicine, the second prize of China Medical Science and Technology Progress Award, and the third prize of Shanghai Medical Science and Technology Award. He is currently a member of the American Heart Association (FACC), a member of the European Society of Cardiology (FESC), a member of the European Society of Hypertension (ESH), and a member of the International Society of Hypertension (ISH). Served as a young editorial board member of "Chinese Journal of Cardiovascular Research", "Chinese Journal of Evidence-Based Medicine" and "Chinese Journal of Interventional Cardiology". Served as a reviewer for journals such as Hypertension and Artificial Intelligence Review. At present, it has obtained 5 national invention patents and 10 utility model patents.
